Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1991-03-29
1993-12-28
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 21, 530324, 530327, 530399, A61K 3724, A61K 39395
Patent
active
052739635
ABSTRACT:
Compositions and methods of use thereof for treating small cell and nonsmall cell lung cancers in mammals are disclosed. The compositions comprise substances that inhibit the lung cancer cell growth and proliferation actions of the biological response modifier vasoactive intestinal polypeptide, such as specific thymosins or analogues, derivatives and fragments thereof, anti-vasoactive intestinal polypeptide receptor polyclonal or monoclonal antibodies, and antibodies directed against the vasoactive intestinal polypeptide molecule itself.
REFERENCES:
patent: 4079127 (1978-03-01), Goldstein et al.
patent: 4082737 (1978-04-01), McGregor et al.
patent: 4560676 (1985-12-01), Merrifield
patent: 4612365 (1986-09-01), Birr et al.
patent: 4910296 (1990-03-01), Birr et al.
Calvo et al., Gen. Pharm. vol. 20, No. 4, pp. 503-505 (1989).
Calvo et al., Biosh. Req. vol. 6, No. 8, pp. 727-734 (1986).
J. Pichon et al., "Anti-Cell Surface Monoclonal . . . (H 29 Cells)", The EMBO Journal, vol. 2, No. 7, issued 1983, pp. 1017-1022.
J. R. Calvo et al., "Interaction of Thymic Peptide . . . with PH1 Secretin", Gen. Pharmac, vol. 20, No. 4, issued 1989, pp. 503-505.
J. R. Calvo et al., "Interactions of Thymic Peptide . . . (VIP) Receptors", Bioscience Reports, vol. 6, No. 8, issued 1986, pp. 727-733.
Shaffer et al., "High Affinity Binding . . . Cancer Cell Lines", Peptides, vol. 8, issued 1987, pp. 1101-1105 see page 1105.
Cuttitta, F., et al., "Bombesin-Like Peptides Can Function . . . ", Nature, 316:823-26 (1985).
Carney, D. N., et al., "Selective Stimulation of Small Cell . . . ", Cancer Research, 47:821-25 (1987).
Mahmoud, S. et al., "Small Cell Lung Cancer Bombesin Receptors . . . ", Life Sciences, 44:367-73 (1989).
Imanishi, K., et al., "Inhibition of Growth of Human . . . ", Journal of the National Cancer Institute, 81:220-23 (1989).
Lee, M., et al., J. Cell Biochem., in press, 1991.
Moody, T. W., et al., "Lung Carcinoid Cell Lines Have Bombesin-Like Peptides . . . ", Journal of Cellular Biochemistry, 43:139-147 (1990).
Lee, M., et al., "Vasoactive Intestinal Polypeptide Binds With High Affinity . . . ", Peptides, 11:1205-209 (1990).
Shaffer, M. M. et al., "High Affinity Binding of VIP . . . ", Peptides, 8:1101-106 (1987).
Cohen, M. H. et al., "Thymosin Fraction V and Intensive Combination . . . ", Journal of the American Medical Association, 241:1813-15 (1979).
Scher, H. I., et al., "Randomized Trial of Combined Modality Therapy . . . ", Cancer Research, 48:1663-70 (1988).
Valdivieso, M., et al., "Chemoimmunotherapy of Non-Small . . . ", Proc. Am. Assoc. Cancer Research and Clinical Oncology, 22:495 (1981).
Bedikian, A. Y., et al., "Prospective Evaluation of Thymosin Fraction V . . . ", American Journal of Clinical Oncology, 7:399-404 (1984).
Dillman, R. O., et al., "Phase II Trial of Thymosin . . . ", Journal of Biological Response Modifiers, 6:263-67 (1987).
Asbell, S. O., et al., "Phase III RTOG Double Blind . . . ", American Society of Clinical Oncology, 9:242 (1990).
Schulof, R. S., et al., "A Randomized Trial . . . ", Journal of Biological Response Modifiers, 4:147-58 (1985).
Koh Choon
The George Washington University
Wityshyn Michael G.
LandOfFree
Compositions and methods for treating small cell and nonsmall ce does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating small cell and nonsmall ce, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating small cell and nonsmall ce will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1542709